168
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer

ORCID Icon, &
Pages 179-191 | Received 01 Feb 2023, Accepted 08 May 2023, Published online: 23 Jun 2023

References

  • Ardito, C. M., B. M. Gruner, K. K. Takeuchi, C. Lubeseder-Martellato, N. Teichmann, P. K. Mazur, K. E. Delgiorno, et al. 2012. “EGF Receptor is Required for KRAS-Induced Pancreatic Tumorigenesis.” Cancer Cell 22 (3): 304–317. https://doi.org/10.1016/j.ccr.2012.07.024
  • Arnold, D., B. Lueza, J. Y. Douillard, M. Peeters, H. J. Lenz, A. Venook, V. Heinemann, et al. 2017. “Prognostic and Predictive Value of Primary Tumor Side in Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Chemotherapy and EGFR Directed Antibodies in Six Randomized Trials.” Annals of Oncology 28 (8): 1713–1729. https://doi.org/10.1093/annonc/mdx175
  • Asif, P. J., C. Longobardi, M. Hahne, and J. P. Medema. 2021. “The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis.” Cancers 13 (18): 4720. https://doi.org/10.3390/cancers13184720
  • Behrenbruch, Corina, Momeneh Foroutan, Phoebe Lind, Jai Smith, Mélodie Grandin, Benjamin Cooper, Carolyn Shembrey, et al. 2021. “Targeting of TP53-Independent Cell Cycle Checkpoints Overcomes FOLFOX Resistance in Metastatic Colorectal Cancer.” bioRxiv:2021.02.04.429849. https://doi.org/10.1101/2021.02.04.429849
  • Berg, K. C. G., P. W. Eide, I. A. Eilertsen, B. Johannessen, J. Bruun, S. A. Danielsen, M. Bjornslett, et al. 2017. “Multi-Omics of 34 Colorectal Cancer Cell Lines–A Resource for Biomedical Studies.” Molecular Cancer 16 (1): 116. https://doi.org/10.1186/s12943-017-0691-y
  • Betge, J., N. I. Schneider, L. Harbaum, M. J. Pollheimer, R. A. Lindtner, P. Kornprat, M. P. Ebert, and C. Langner. 2016. “MUC1, MUC2, MUC5AC, and MUC6 in Colorectal Cancer: Expression Profiles and Clinical Significance.” Virchows Archiv 469 (3): 255–265. https://doi.org/10.1007/s00428-016-1970-5
  • Carpinteri, S., S. Sampurno, M. P. Bernardi, M. Germann, J. Malaterre, A. Heriot, B. A. Chambers, S. E. Mutsaers, A. C. Lynch, and R. G. Ramsay. 2015. “Peritoneal Tumorigenesis and Inflammation Are Ameliorated by Humidified-Warm Carbon Dioxide Insufflation in the Mouse.” Annals of Surgical Oncology 22 (Suppl 3): S1540–S7. https://doi.org/10.1245/s10434-015-4508-1
  • Castle, J. C., M. Loewer, S. Boegel, J. de Graaf, C. Bender, A. D. Tadmor, V. Boisguerin, et al. 2014. “Immunomic, Genomic and Transcriptomic Characterization of CT26 Colorectal Carcinoma.” BMC Genomics 15 (1): 190. https://doi.org/10.1186/1471-2164-15-190
  • Cattaneo, C. M., K. K. Dijkstra, L. F. Fanchi, S. Kelderman, S. Kaing, N. van Rooij, S. van den Brink, T. N. Schumacher, and E. E. Voest. 2020. “Tumor organoid-T-Cell Coculture Systems.” Nature Protocols 15 (1): 15–39. https://doi.org/10.1038/s41596-019-0232-9
  • Ceelen, W., R. G. Ramsay, V. Narasimhan, A. G. Heriot, and O. De Wever. 2020. “Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases.” Trends in Cancer 6 (3): 236–246. https://doi.org/10.1016/j.trecan.2019.12.008
  • Cheasley, D., L. Pereira, S. Lightowler, E. Vincan, J. Malaterre, and R. G. Ramsay. 2011. “Myb Controls Intestinal Stem Cell Genes and Self-Renewal.” Stem Cells 29 (12): 2042–2050. https://doi.org/10.1002/stem.761
  • Cheasley, D., L. Pereira, S. Sampurno, O. Sieber, R. Jorissen, H. Xu, M. Germann, Y. Yuqian, R. G. Ramsay, and J. Malaterre. 2015. “Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis.” Molecular Cancer Research 13 (8): 1185–1196. https://doi.org/10.1158/1541-7786.MCR-15-0014
  • Chen, B., C. R. Scurrah, E. T. McKinley, A. J. Simmons, M. A. Ramirez-Solano, X. Zhu, N. O. Markham, et al. 2021. “Differential Pre-Malignant Programs and Microenvironment Chart Distinct Paths to Malignancy in Human Colorectal Polyps.” Cell 184 (26): 6262–6280.e26. https://doi.org/10.1016/j.cell.2021.11.031
  • Chen, W., B. J. Swanson, and W. L. Frankel. 2017. “Molecular Genetics of Microsatellite-Unstable Colorectal Cancer for Pathologists.” Diagnostic Pathology 12 (1): 24. https://doi.org/10.1186/s13000-017-0613-8
  • Cortes-Guiral, D., M. Hubner, M. Alyami, A. Bhatt, W. Ceelen, O. Glehen, F. Lordick, et al. 2021. “Primary and Metastatic Peritoneal Surface Malignancies.” Nature Reviews. Disease Primers 7 (1): 91. https://doi.org/10.1038/s41572-021-00326-6
  • Cremolini, C., C. Antoniotti, S. Lonardi, F. Bergamo, E. Cortesi, G. Tomasello, R. Moretto, et al. 2018. “Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer. Retrospective Analysis of the TRIBE Trial by GONO.” Annals of Oncology 29 (7): 1528–1534. https://doi.org/10.1093/annonc/mdy140
  • Dakowicz, D., M. Zajkowska, and B. Mroczko. 2022. “Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer.” International Journal of Molecular Sciences 23 (6): 3375. https://doi.org/10.3390/ijms23063375
  • Derynck, R., Y. Zhang, and X. H. Feng. 1998. “Smads: transcriptional Activators of TGF-Beta Responses.” Cell 95 (6): 737–740. https://doi.org/10.1016/s0092-8674(00)81696-7
  • Dignass, A. U., and A. Sturm. 2001. “Peptide Growth Factors in the Intestine.” European Journal of Gastroenterology & Hepatology 13 (7): 763–770. https://doi.org/10.1097/00042737-200107000-00002
  • Drost, J., R. H. van Jaarsveld, B. Ponsioen, C. Zimberlin, R. van Boxtel, A. Buijs, N. Sachs, et al. 2015. “Sequential Cancer Mutations in Cultured Human Intestinal Stem Cells.” Nature 521 (7550): 43–47. https://doi.org/10.1038/nature14415
  • Efremova, M., D. Rieder, V. Klepsch, P. Charoentong, F. Finotello, H. Hackl, N. Hermann-Kleiter, et al. 2018. “Targeting Immune Checkpoints Potentiates Immunoediting and Changes the Dynamics of Tumor Evolution.” Nature Communications 9 (1): 32. https://doi.org/10.1038/s41467-017-02424-0
  • Fearon, E. R., and B. Vogelstein. 1990. “A Genetic Model for Colorectal Tumorigenesis.” Cell 61 (5): 759–767. https://doi.org/10.1016/0092-8674(90)90186-i
  • Flood, M., V. Narasimhan, K. Wilson, W. M. Lim, R. Ramsay, M. Michael, and A. Heriot. 2022. “Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.” Annals of Surgical Oncology 29 (1): 47–59. https://doi.org/10.1245/s10434-021-10829-x
  • Fre, S., S. K. Pallavi, M. Huyghe, M. Lae, K. P. Janssen, S. Robine, S. Artavanis-Tsakonas, and D. Louvard. 2009. “Notch and Wnt Signals Cooperatively Control Cell Proliferation and Tumorigenesis in the Intestine.” Proceedings of the National Academy of Sciences of the United States of America 106 (15): 6309–6314. https://doi.org/10.1073/pnas.0900427106
  • Fuhr, L., R. El-Athman, R. Scrima, O. Cela, A. Carbone, H. Knoop, Y. Li, et al. 2018. “The Circadian Clock Regulates Metabolic Phenotype Rewiring via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer.” EBio Medicine 33: 105–121. https://doi.org/10.1016/j.ebiom.2018.07.002
  • Fujii, M., and T. Sato. 2017. “Defining the Role of Lgr5(+) Stem Cells in Colorectal Cancer: From Basic Research to Clinical Applications.” Genome Medicine 9 (1): 66. https://doi.org/10.1186/s13073-017-0460-y
  • Fujii, M., M. Shimokawa, S. Date, A. Takano, M. Matano, K. Nanki, Y. Ohta, et al. 2016. “A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.” Cell Stem Cell 18 (6): 827–838. https://doi.org/10.1016/j.stem.2016.04.003
  • Gagos, S., V. L. Hopwood, D. Iliopoulos, A. Kostakis, P. Karayannakos, H. Yatzides, G. D. Skalkeas, and S. Pathak. 1995. “Chromosomal Markers Associated with Metastasis in Two Colon Cancer Cell Lines Established from the Same Patient.” Anticancer Res.15 (2): 369–378.
  • Ganesh, K., C. Wu, K. P. O’Rourke, B. C. Szeglin, Y. Zheng, C. G. Sauve, M. Adileh, et al. 2019. “A Rectal Cancer Organoid Platform to Study Individual Responses to Chemoradiation.” Nature Medicine 25 (10): 1607–1614. https://doi.org/10.1038/s41591-019-0584-2
  • Germann, M., H. Xu, J. Malaterre, S. Sampurno, M. Huyghe, D. Cheasley, S. Fre, and R. G. Ramsay. 2014. “Tripartite Interactions between Wnt Signaling, Notch and Myb for Stem/Progenitor Cell Functions during Intestinal Tumorigenesis.” Stem Cell Research 13 (3 Pt A): 355–366. https://doi.org/10.1016/j.scr.2014.08.002
  • Go, Y. H., W. H. Choi, W. J. Bae, S. I. Jung, C. H. Cho, S. A. Lee, J. S. Park, et al. 2022. “Modeling Pancreatic Cancer with Patient-Derived Organoids Integrating Cancer-Associated Fibroblasts.” Cancers 14 (9): 2077. https://doi.org/10.3390/cancers14092077
  • Greenlee, J. D., and M. R. King. 2022. “A Syngeneic MC38 Orthotopic Mouse Model of Colorectal Cancer Metastasis.” Biology Methods & Protocols 7 (1): bpac024. https://doi.org/10.1093/biomethods/bpac024
  • Guinney, J., R. Dienstmann, X. Wang, A. de Reynies, A. Schlicker, C. Soneson, L. Marisa, et al. 2015. “The Consensus Molecular Subtypes of Colorectal Cancer.” Nature Medicine 21 (11): 1350–1356. https://doi.org/10.1038/nm.3967
  • Hadadi, E., W. Taylor, X. M. Li, Y. Aslan, M. Villote, J. Riviere, G. Duvallet, et al. 2020. “Chronic Circadian Disruption Modulates Breast Cancer Stemness and Immune Microenvironment to Drive Metastasis in Mice.” Nature Communications 11 (1): 3193. https://doi.org/10.1038/s41467-020-16890-6
  • Hayashi, Y., M. Tsujii, T. Kodama, T. Akasaka, J. Kondo, H. Hikita, T. Inoue, et al. 2016. “p53 Functional Deficiency in Human Colon Cancer Cells Promotes Fibroblast-Mediated Angiogenesis and Tumor Growth.” Carcinogenesis 37 (10): 972–984. https://doi.org/10.1093/carcin/bgw085
  • Hirokawa, Y., J. Clarke, M. Palmieri, T. Tan, D. Mouradov, S. Li, C. Lin, et al. 2021. “Low-Viscosity Matrix Suspension Culture Enables Scalable Analysis of Patient-Derived Organoids and Tumoroids from the Large Intestine.” Communications Biology 4 (1): 1067. https://doi.org/10.1038/s42003-021-02607-y
  • Huang, B., M. Huang, and Q. Li. 2019. “Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway.” Technology in Cancer Research & Treatment 18: 1533033819879905. https://doi.org/10.1177/1533033819879905
  • Huang, J. J., and G. C. Blobe. 2016. “Dichotomous Roles of TGF-Beta in Human Cancer.” Biochemical Society Transactions 44 (5): 1441–1454. https://doi.org/10.1042/BST20160065
  • Iacopetta, B. 2002. “Are There Two Sides to Colorectal Cancer?” International Journal of Cancer 101 (5): 403–408. https://doi.org/10.1002/ijc.10635
  • Jass, J. R. 1983. “Relation between Metaplastic Polyp and Carcinoma of the Colorectum.” Lancet 1 (8314-5): 28–30. https://doi.org/10.1016/s0140-6736(83)91564-7
  • Jenkins, R. W., A. R. Aref, P. H. Lizotte, E. Ivanova, S. Stinson, C. W. Zhou, M. Bowden, et al. 2018. “Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.” Cancer Discovery 8 (2): 196–215. https://doi.org/10.1158/2159-8290.CD-17-0833
  • Joanito, I., P. Wirapati, N. Zhao, Z. Nawaz, G. Yeo, F. Lee, C. L. P. Eng, et al. 2022. “Single-Cell and Bulk Transcriptome Sequencing Identifies Two Epithelial Tumor Cell States and Refines the Consensus Molecular Classification of Colorectal Cancer.” Nature Genetics 54 (7): 963–975. https://doi.org/10.1038/s41588-022-01100-4
  • Katoh, M. 2016. “FGFR Inhibitors: Effects on Cancer Cells, Tumor Microenvironment and Whole-Body Homeostasis (Review).” International Journal of Molecular Medicine 38 (1): 3–15. https://doi.org/10.3892/ijmm.2016.2620
  • Khaliq, A. M., C. Erdogan, Z. Kurt, S. S. Turgut, M. W. Grunvald, T. Rand, S. Khare, et al. 2022. “Refining Colorectal Cancer Classification and Clinical Stratification through a Single-Cell Atlas.” Genome Biology 23 (1): 113. https://doi.org/10.1186/s13059-022-02677-z
  • Kim, K. A., M. Kakitani, J. Zhao, T. Oshima, T. Tang, M. Binnerts, Y. Liu, et al. 2005. “Mitogenic Influence of Human R-spondin1 on the Intestinal Epithelium.” Science 309 (5738): 1256–1259. https://doi.org/10.1126/science.1112521
  • Kong, J. C., M. Flood, R. G. Ramsay, S. K. Warrier, and A. Heriot. 2021. “Shifting the Treatment Paradigm for Patients with Deficient Mismatch Repair Colon Cancer: Is There a Role for Immunotherapy?” ANZ Journal of Surgery 91 (5): 778–780. https://doi.org/10.1111/ans.16485
  • Kong, J. C. H., G. R. Guerra, R. M. Millen, S. Roth, H. Xu, P. J. Neeson, P. K. Darcy, et al. 2018. “Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.” JCO Precision Oncology 2: 1–15. https://doi.org/10.1200/PO.18.00075
  • Lannagan, T. R. M., Y. K. Lee, T. Wang, J. Roper, M. L. Bettington, L. Fennell, L. Vrbanac, et al. 2019. “Genetic Editing of Colonic Organoids Provides a Molecularly Distinct and Orthotopic Preclinical Model of Serrated Carcinogenesis.” Gut 68 (4): 684–692. https://doi.org/10.1136/gutjnl-2017-315920
  • Li, C., D. Zuo, L. Yin, Y. Lin, C. Li, T. Liu, and L. Wang. 2018. “Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.” Gastroenterology Research and Practice 2018: 6986870. https://doi.org/10.1155/2018/6986870
  • Li, H., E. T. Courtois, D. Sengupta, Y. Tan, K. H. Chen, J. J. L. Goh, S. L. Kong, et al. 2017. “Reference Component Analysis of Single-Cell Transcriptomes Elucidates Cellular Heterogeneity in Human Colorectal Tumors.” Nature Genetics 49 (5): 708–718. https://doi.org/10.1038/ng.3818
  • Lim, J. T. C., L. G. Kwang, N. C. W. Ho, C. C. M. Toh, N. S. H. Too, L. Hooi, T. Benoukraf, et al. 2022. “Hepatocellular Carcinoma Organoid co-Cultures Mimic Angiocrine Crosstalk to Generate Inflammatory Tumor Microenvironment.” Biomaterials 284: 121527. https://doi.org/10.1016/j.biomaterials.2022.121527
  • Linnekamp, J. F., S. R. V. Hooff, P. R. Prasetyanti, R. Kandimalla, J. Y. Buikhuisen, E. Fessler, P. Ramesh, et al. 2018. “Consensus Molecular Subtypes of Colorectal Cancer Are Recapitulated in in Vitro and in Vivo Models.” Cell Death and Differentiation 25 (3): 616–633. https://doi.org/10.1038/s41418-017-0011-5
  • Loree, J. M., and S. Kopetz. 2017. “Recent Developments in the Treatment of Metastatic Colorectal Cancer.” Therapeutic Advances in Medical Oncology 9 (8): 551–564. https://doi.org/10.1177/1758834017714997
  • Loree, J. M., A. A. L. Pereira, M. Lam, A. N. Willauer, K. Raghav, A. Dasari, V. K. Morris, et al. 2018. “Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.” Clinical Cancer Research 24 (5): 1062–1072. https://doi.org/10.1158/1078-0432.CCR-17-2484
  • Malaterre, J., M. Carpinelli, M. Ernst, W. Alexander, M. Cooke, S. Sutton, S. Dworkin, et al. 2007. “c-Myb is Required for Progenitor Cell Homeostasis in Colonic Crypts.” Proceedings of the National Academy of Sciences of the United States of America 104 (10): 3829–3834. https://doi.org/10.1073/pnas.0610055104
  • Malaterre, J., L. Pereira, T. Putoczki, R. Millen, S. Paquet-Fifield, M. Germann, J. Liu, et al. 2016. “Intestinal-Specific Activatable Myb Initiates Colon Tumorigenesis in Mice.” Oncogene 35 (19): 2475–2484. https://doi.org/10.1038/onc.2015.305
  • Marshall, L. J., M. Triunfol, and T. Seidle. 2020. “Patient-Derived Xenograft vs. Organoids: A Preliminary Analysis of Cancer Research Output, Funding and Human Health Impact in 2014–2019.” Animals 10 (10): 1923. https://doi.org/10.3390/ani10101923
  • Martin, S. Z., D. C. Wagner, N. Horner, D. Horst, H. Lang, K. E. Tagscherer, and W. Roth. 2019. “Ex Vivo Tissue Slice Culture System to Measure Drug-Response Rates of Hepatic Metastatic Colorectal Cancer.” BMC Cancer 19 (1): 1030. https://doi.org/10.1186/s12885-019-6270-4
  • Michie, J., P. A. Beavis, A. J. Freeman, S. J. Vervoort, K. M. Ramsbottom, V. Narasimhan, E. J. Lelliott, et al. 2019. “Antagonism of IAPs Enhances CAR T-Cell Efficacy.” Cancer Immunology Research 7 (2): 183–192. https://doi.org/10.1158/2326-6066.CIR-18-0428
  • Moore, S. R., J. Pruszka, J. Vallance, E. Aihara, T. Matsuura, M. H. Montrose, N. F. Shroyer, and C. I. Hong. 2014. “Robust Circadian Rhythms in Organoid Cultures from PERIOD2::LUCIFERASE Mouse Small Intestine.” Disease Models & Mechanisms 7 (9): 1123–1130. https://doi.org/10.1242/dmm.014399
  • Narasimhan, V., J. A. Wright, M. Churchill, T. Wang, R. Rosati, T. R. M. Lannagan, L. Vrbanac, et al. 2020. “Medium-Throughput Drug Screening of Patient-Derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.” Clinical Cancer Research 26 (14): 3662–3670. https://doi.org/10.1158/1078-0432.CCR-20-0073
  • Nusse, R., and H. Clevers. 2017. “Wnt/beta-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.” Cell 169 (6): 985–999. https://doi.org/10.1016/j.cell.2017.05.016
  • Ooft, S. N., F. Weeber, K. K. Dijkstra, C. M. McLean, S. Kaing, E. van Werkhoven, L. Schipper, et al. 2019. “Patient-Derived Organoids Can Predict Response to Chemotherapy in Metastatic Colorectal Cancer Patients.” Science Translational Medicine 11 (513): . ay2574 https://doi.org/10.1126/scitranslmed.aay2574.
  • Pellino, G., O. Warren, S. Mills, S. Rasheed, P. P. Tekkis, and C. Kontovounisios. 2018. “Comparison of Western and Asian Guidelines concerning the Management of Colon Cancer.” Diseases of the Colon and Rectum 61 (2): 250–259. https://doi.org/10.1097/DCR.0000000000001012
  • Riggins, G. J., K. W. Kinzler, B. Vogelstein, and S. Thiagalingam. 1997. “Frequency of Smad Gene Mutations in Human Cancers.” Cancer Res 57 (13): 2578–2580.
  • Rosselot, A. E., M. Park, M. Kim, T. Matsu-Ura, G. Wu, D. E. Flores, K. R. Subramanian, et al. 2022. “Ontogeny and Function of the Circadian Clock in Intestinal Organoids.” The EMBO Journal 41 (2): e106973. https://doi.org/10.15252/embj.2020106973
  • Sato, T., and H. Clevers. 2015. “SnapShot: Growing Organoids from Stem Cells.” Cell 161 (7): 1700–17e1. https://doi.org/10.1016/j.cell.2015.06.028
  • Sato, T., D. E. Stange, M. Ferrante, R. G. Vries, J. H. Van Es, S. Van den Brink, W. J. Van Houdt, et al. 2011. “Long-Term Expansion of Epithelial Organoids from Human Colon, Adenoma, Adenocarcinoma, and Barrett’s Epithelium.” Gastroenterology 141 (5): 1762–1772. https://doi.org/10.1053/j.gastro.2011.07.050
  • Sato, T., J. H. van Es, H. J. Snippert, D. E. Stange, R. G. Vries, M. van den Born, N. Barker, N. F. Shroyer, M. van de Wetering, and H. Clevers. 2011. “Paneth Cells Constitute the Niche for Lgr5 Stem Cells in Intestinal Crypts.” Nature 469 (7330): 415–418. https://doi.org/10.1038/nature09637
  • Schuth, Sebastian, Solange Le Blanc, Teresa G. Krieger, Julia Jabs, Miriam Schenk, Nathalia A. Giese, Markus W. Büchler, Roland Eils, Christian Conrad, and Oliver Strobel. 2022. “Patient-Specific Modeling of Stroma-Mediated Chemoresistance of Pancreatic Cancer Using a Three-Dimensional Organoid-Fibroblast co-Culture System.” Journal of Experimental & Clinical Cancer Research 41 (1): 312. https://doi.org/10.1186/s13046-022-02519-7
  • Shembrey, Carolyn, Jai Smith, Mélodie Grandin, Nathalia Williams, Hyun-Jung Cho, Christina Mølck, Corina Behrenbruch, et al. 2022. “Longitudinal Monitoring of Intra-Tumoral Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumor Models.” Cancers 14 (3): 581. https://doi.org/10.3390/cancers14030581
  • Stintzing, S., P. Wirapati, H. J. Lenz, D. Neureiter, L. Fischer von Weikersthal, T. Decker, A. Kiani, et al. 2019. “Consensus Molecular Subgroups (CMS) of Colorectal Cancer (CRC) and First-Line Efficacy of FOLFIRI plus Cetuximab or Bevacizumab in the FIRE3 (AIO KRK-0306) Trial.” Annals of Oncology 30 (11): 1796–1803. https://doi.org/10.1093/annonc/mdz387
  • Stokes, K., M. Nunes, C. Trombley, Defl Flores, G. Wu, Z. Taleb, A. Alkhateeb, et al. 2021. “The Circadian Clock Gene, Bmal1, Regulates Intestinal Stem Cell Signaling and Represses Tumor Initiation.” Cellular and Molecular Gastroenterology and Hepatology 12 (5): 1847–1872 e0. https://doi.org/10.1016/j.jcmgh.2021.08.001
  • Sulli, G., M. T. Y. Lam, and S. Panda. 2019. “Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment.” Trends in Cancer 5 (8): 475–494. https://doi.org/10.1016/j.trecan.2019.07.002
  • Sveen, A., J. Bruun, P. W. Eide, I. A. Eilertsen, L. Ramirez, A. Murumagi, M. Arjama, et al. 2018. “Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.” Clinical Cancer Research 24 (4): 794–806. https://doi.org/10.1158/1078-0432.CCR-17-1234
  • Tan, T., Y. Hirokawa, J. Clarke, A. Sakthianandeswaren, and O. M. Sieber. 2022. “Low-Viscosity Matrix Suspension Culture for Human Colorectal Epithelial Organoids and Tumoroids.” Bio-protocol 12 (8): e4394. https://doi.org/10.21769/BioProtoc.4394
  • Trumpi, K., I. Ubink, A. Trinh, M. Djafarihamedani, J. M. Jongen, K. M. Govaert, S. G. Elias, et al. 2017. “Neoadjuvant Chemotherapy Affects Molecular Classification of Colorectal Tumors.” Oncogenesis 6 (7): e357. https://doi.org/10.1038/oncsis.2017.48
  • Ubink, I., W. J. van Eden, P. Snaebjornsson, N. F. M. Kok, J. van Kuik, W. M. U. van Grevenstein, M. M. Lacle, et al. 2018. “Histopathological and Molecular Classification of Colorectal Cancer and Corresponding Peritoneal Metastases.” The British Journal of Surgery 105 (2): e204–e11. https://doi.org/10.1002/bjs.10788
  • van de Wetering, M., H. E. Francies, J. M. Francis, G. Bounova, F. Iorio, A. Pronk, W. van Houdt, et al. 2015. “Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients.” Cell 161 (4): 933–945. https://doi.org/10.1016/j.cell.2015.03.053
  • Varga, J., A. Nicolas, V. Petrocelli, M. Pesic, A. Mahmoud, B. E. Michels, E. Etlioglu, et al. 2020. “AKT-Dependent NOTCH3 Activation Drives Tumor Progression in a Model of Mesenchymal Colorectal Cancer.” Journal of Experimental Medicine 217 (10): . 0191515 https://doi.org/10.1084/jem.20191515.
  • Varinelli, Luca, Marcello Guaglio, Silvia Brich, Susanna Zanutto, Antonino Belfiore, Federica Zanardi, Fabio Iannelli, et al. 2021. “Decellularized Normal and Tumor Scaffolds for Cancer Organoid Cultures as a Model of Colorectal Peritoneal Metastases.” bioRxiv:2021.07.15.452437. https://doi.org/10.1101/2021.07.15.452437
  • Vincan, E., P. K. Darcy, C. A. Farrelly, M. C. Faux, T. Brabletz, and R. G. Ramsay. 2007. “Frizzled-7 Dictates Three-Dimensional Organization of Colorectal Cancer Cell Carcinoids.” Oncogene 26 (16): 2340–2352. https://doi.org/10.1038/sj.onc.1210026
  • Wang, F., J. Long, L. Li, Z. B. Zhao, F. Wei, Y. Yao, W. J. Qiu, et al. 2020. “Mutations in the Notch Signaling Pathway Are Associated with Enhanced anti-Tumor Immunity in Colorectal Cancer.” Journal of Cellular and Molecular Medicine 24 (20): 12176–12187. https://doi.org/10.1111/jcmm.15867
  • Wang, J., Z. Xu, Z. Wang, G. Du, and L. Lun. 2021. “TGF-Beta Signaling in Cancer Radiotherapy.” Cytokine 148: 155709. https://doi.org/10.1016/j.cyto.2021.155709
  • Wang, X., Y. Yamamoto, L. H. Wilson, T. Zhang, B. E. Howitt, M. A. Farrow, F. Kern, et al. 2015. “Cloning and Variation of Ground State Intestinal Stem Cells.” Nature 522 (7555): 173–178. https://doi.org/10.1038/nature14484
  • Weeber, F., S. N. Ooft, K. K. Dijkstra, and E. E. Voest. 2017. “Tumor Organoids as a Pre-Clinical Cancer Model for Drug Discovery.” Cell Chemical Biology 24 (9): 1092–1100. https://doi.org/10.1016/j.chembiol.2017.06.012
  • Weng, A. P., A. A. Ferrando, W. Lee, J. P. Th Morris, L. B. Silverman, C. Sanchez-Irizarry, S. C. Blacklow, A. T. Look, and J. C. Aster. 2004. “Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia.” Science 306 (5694): 269–271. https://doi.org/10.1126/science.1102160
  • Whitehead, R. H., K. Demmler, S. P. Rockman, and N. K. Watson. 1999. “Clonogenic Growth of Epithelial Cells from Normal Colonic Mucosa from Both Mice and Humans.” Gastroenterology 117 (4): 858–865. https://doi.org/10.1016/s0016-5085(99)70344-6
  • Xu, H., Y. Yan, S. Deb, D. Rangasamy, M. Germann, J. Malaterre, N. C. Eder, et al. 2014. “Cohesin Rad21 Mediates Loss of Heterozygosity and is Upregulated via Wnt Promoting Transcriptional Dysregulation in Gastrointestinal Tumors.” Cell Reports 9 (5): 1781–1797. https://doi.org/10.1016/j.celrep.2014.10.059
  • Yamamoto, T., K. Kawada, Y. Itatani, S. Inamoto, R. Okamura, M. Iwamoto, E. Miyamoto, et al. 2017. “Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.” Clinical Cancer Research 23 (3): 833–844. https://doi.org/10.1158/1078-0432.CCR-16-0520
  • You, Y. N., K. M. Hardiman, A. Bafford, V. Poylin, T. D. Francone, K. Davis, I. M. Paquette, et al. 2020. “The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer.” Diseases of the Colon and Rectum 63 (9): 1191–1222. https://doi.org/10.1097/DCR.0000000000001762
  • Zhang, J., B. Chen, H. Li, Y. Wang, X. Liu, K. Y. Wong, W. N. Chan, et al. 2022. “Cancer-Associated Fibroblasts Potentiate Colorectal Cancer Progression by Crosstalk of the IGF2-IGF1R and Hippo-YAP1 Signaling Pathways.” The Journal of Pathology, 2022, 033 doi: 10.1002/path.6033.
  • Zhong, W., J. S. Myers, F. Wang, K. Wang, J. Lucas, E. Rosfjord, J. Lucas, et al. 2020. “Comparison of the Molecular and Cellular Phenotypes of Common Mouse Syngeneic Models with Human Tumors.” BMC Genomics 21 (1): 2. https://doi.org/10.1186/s12864-019-6344-3
  • Zorbas, M., C. Sicurella, I. Bertoncello, D. Venter, S. Ellis, M. L. Mucenski, and R. G. Ramsay. 1999. “c-Myb is Critical for Murine Colon Development.” Oncogene 18 (42): 5821–5830. https://doi.org/10.1038/sj.onc.1202971

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.